Is BECTON DICKINSON & CO (BDX) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 31.7% / 30% | 1.1% / 30% | 4.9% / 30% | 0.17% / 5% | ✗ NOT HALAL |
| DJIM | 31.7% / 33% | 1.1% / 33% | 4.9% / 33% | 0.17% / 5% | ✓ HALAL |
| MSCI | 34.7% / 33% | 1.2% / 33% | 5.4% / 33% | 0.17% / 5% | ✗ NOT HALAL |
| S&P | 31.7% / 33% | 1.1% / 33% | 4.9% / 33% | 0.17% / 5% | ✓ HALAL |
| FTSE | 34.7% / 33% | 1.2% / 33% | 5.4% / 50% | 0.17% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 46.8% | |
| Operating Margin | 13.3% | |
| Net Margin | 8.0% | |
| Return on Equity (ROE) | 7.0% | |
| Return on Assets (ROA) | 4.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $3.4B |
| Free Cash Flow | $2.7B |
| Total Debt | $19.2B |
| Debt-to-Equity | 77.3 |
| Current Ratio | 1.0 |
| Total Assets | $55.3B |
Price & Trading
| Last Close | $157.38 |
| 50-Day MA | $166.39 |
| 200-Day MA | $152.11 |
| Avg Volume | 2.7M |
| Beta | 0.3 |
|
52-Week Range
$127.59
| |
About BECTON DICKINSON & CO (BDX)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BECTON DICKINSON & CO (BDX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BECTON DICKINSON & CO is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BECTON DICKINSON & CO's debt ratio?
BECTON DICKINSON & CO's debt ratio is 31.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 34.7%.
What are BECTON DICKINSON & CO's key financial metrics?
BECTON DICKINSON & CO has a market capitalization of $56.0B, trailing P/E ratio of 25.2, and revenue of $21.8B. The company maintains a gross margin of 46.8% and a net margin of 8.0%. Return on equity stands at 7.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.